Declaratory Judgments Win As Federal Circuit Tweaks Standards For ANDA Suits
Executive Summary
The parameters under which generic drug firms can seek declaratory judgments against patent holders have been expanded under a ruling by the U.S. Court of Appeals for the Federal Circuit